CD59 and Buschke-Ollendorff syndrome: We hypothesize a model in which chronic inflammation, a hallmark of BOS development, results in cellular activation, presumably of endothelial or epithelial cells, and increased expression of CD59 which is then shed from the cell surface and detectable at increased levels in the circulation.